SOD3 and Alzheimer disease: For instance, Sah et al. (2018) found that superoxide dismutase 3-transduced MSCs ameliorated AD pathology and enhanced the efficacy of MSC therapy by controlling activated immune cells, reducing expression levels of pro-inflammatory mediators in the skin of AD mice.